IBDEI2U9 ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,45278,2)
;;=^5002524
;;^UTILITY(U,$J,358.3,45279,0)
;;=E09.42^^172^2262^11
;;^UTILITY(U,$J,358.3,45279,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45279,1,3,0)
;;=3^DM drug-induced w/ neurological compl w/ diabetic polyneuropathy
;;^UTILITY(U,$J,358.3,45279,1,4,0)
;;=4^E09.42
;;^UTILITY(U,$J,358.3,45279,2)
;;=^5002566
;;^UTILITY(U,$J,358.3,45280,0)
;;=E10.42^^172^2262^4
;;^UTILITY(U,$J,358.3,45280,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45280,1,3,0)
;;=3^DM Type 1 w/ diabetic polyneuropathy
;;^UTILITY(U,$J,358.3,45280,1,4,0)
;;=4^E10.42
;;^UTILITY(U,$J,358.3,45280,2)
;;=^5002606
;;^UTILITY(U,$J,358.3,45281,0)
;;=E10.65^^172^2262^5
;;^UTILITY(U,$J,358.3,45281,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45281,1,3,0)
;;=3^DM Type 1 w/ hyperglycemia
;;^UTILITY(U,$J,358.3,45281,1,4,0)
;;=4^E10.65
;;^UTILITY(U,$J,358.3,45281,2)
;;=^5002623
;;^UTILITY(U,$J,358.3,45282,0)
;;=E10.9^^172^2262^6
;;^UTILITY(U,$J,358.3,45282,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45282,1,3,0)
;;=3^DM Type 1 w/o complications
;;^UTILITY(U,$J,358.3,45282,1,4,0)
;;=4^E10.9
;;^UTILITY(U,$J,358.3,45282,2)
;;=^5002626
;;^UTILITY(U,$J,358.3,45283,0)
;;=E11.42^^172^2262^7
;;^UTILITY(U,$J,358.3,45283,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45283,1,3,0)
;;=3^DM Type 2 w/ diabetic polyneuropathy
;;^UTILITY(U,$J,358.3,45283,1,4,0)
;;=4^E11.42
;;^UTILITY(U,$J,358.3,45283,2)
;;=^5002646
;;^UTILITY(U,$J,358.3,45284,0)
;;=E11.65^^172^2262^8
;;^UTILITY(U,$J,358.3,45284,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45284,1,3,0)
;;=3^DM Type 2 w/ hyperglycemia
;;^UTILITY(U,$J,358.3,45284,1,4,0)
;;=4^E11.65
;;^UTILITY(U,$J,358.3,45284,2)
;;=^5002663
;;^UTILITY(U,$J,358.3,45285,0)
;;=E11.9^^172^2262^9
;;^UTILITY(U,$J,358.3,45285,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45285,1,3,0)
;;=3^DM Type 2 w/o complications
;;^UTILITY(U,$J,358.3,45285,1,4,0)
;;=4^E11.9
;;^UTILITY(U,$J,358.3,45285,2)
;;=^5002666
;;^UTILITY(U,$J,358.3,45286,0)
;;=E13.42^^172^2262^12
;;^UTILITY(U,$J,358.3,45286,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45286,1,3,0)
;;=3^DM oth w/ diabetic polyneuropathy
;;^UTILITY(U,$J,358.3,45286,1,4,0)
;;=4^E13.42
;;^UTILITY(U,$J,358.3,45286,2)
;;=^5002686
;;^UTILITY(U,$J,358.3,45287,0)
;;=E16.2^^172^2262^22
;;^UTILITY(U,$J,358.3,45287,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45287,1,3,0)
;;=3^Hypoglycemia, unspecified
;;^UTILITY(U,$J,358.3,45287,1,4,0)
;;=4^E16.2
;;^UTILITY(U,$J,358.3,45287,2)
;;=^5002708
;;^UTILITY(U,$J,358.3,45288,0)
;;=E46.^^172^2262^26
;;^UTILITY(U,$J,358.3,45288,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45288,1,3,0)
;;=3^Malnutrition, protein-calorie, unspec
;;^UTILITY(U,$J,358.3,45288,1,4,0)
;;=4^E46.
;;^UTILITY(U,$J,358.3,45288,2)
;;=^5002790
;;^UTILITY(U,$J,358.3,45289,0)
;;=E53.8^^172^2262^31
;;^UTILITY(U,$J,358.3,45289,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45289,1,3,0)
;;=3^Vitamin B group deficiency
;;^UTILITY(U,$J,358.3,45289,1,4,0)
;;=4^E53.8
;;^UTILITY(U,$J,358.3,45289,2)
;;=^5002797
;;^UTILITY(U,$J,358.3,45290,0)
;;=E66.01^^172^2262^27
;;^UTILITY(U,$J,358.3,45290,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45290,1,3,0)
;;=3^Obesity, morbid
;;^UTILITY(U,$J,358.3,45290,1,4,0)
;;=4^E66.01
;;^UTILITY(U,$J,358.3,45290,2)
;;=^5002826
;;^UTILITY(U,$J,358.3,45291,0)
;;=E66.9^^172^2262^28
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2U9 3780 printed Dec 13, 2024@02:35:56 Page 2
IBDEI2U9 ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,45278,2)
+2 ;;=^5002524
+3 ;;^UTILITY(U,$J,358.3,45279,0)
+4 ;;=E09.42^^172^2262^11
+5 ;;^UTILITY(U,$J,358.3,45279,1,0)
+6 ;;=^358.31IA^4^2
+7 ;;^UTILITY(U,$J,358.3,45279,1,3,0)
+8 ;;=3^DM drug-induced w/ neurological compl w/ diabetic polyneuropathy
+9 ;;^UTILITY(U,$J,358.3,45279,1,4,0)
+10 ;;=4^E09.42
+11 ;;^UTILITY(U,$J,358.3,45279,2)
+12 ;;=^5002566
+13 ;;^UTILITY(U,$J,358.3,45280,0)
+14 ;;=E10.42^^172^2262^4
+15 ;;^UTILITY(U,$J,358.3,45280,1,0)
+16 ;;=^358.31IA^4^2
+17 ;;^UTILITY(U,$J,358.3,45280,1,3,0)
+18 ;;=3^DM Type 1 w/ diabetic polyneuropathy
+19 ;;^UTILITY(U,$J,358.3,45280,1,4,0)
+20 ;;=4^E10.42
+21 ;;^UTILITY(U,$J,358.3,45280,2)
+22 ;;=^5002606
+23 ;;^UTILITY(U,$J,358.3,45281,0)
+24 ;;=E10.65^^172^2262^5
+25 ;;^UTILITY(U,$J,358.3,45281,1,0)
+26 ;;=^358.31IA^4^2
+27 ;;^UTILITY(U,$J,358.3,45281,1,3,0)
+28 ;;=3^DM Type 1 w/ hyperglycemia
+29 ;;^UTILITY(U,$J,358.3,45281,1,4,0)
+30 ;;=4^E10.65
+31 ;;^UTILITY(U,$J,358.3,45281,2)
+32 ;;=^5002623
+33 ;;^UTILITY(U,$J,358.3,45282,0)
+34 ;;=E10.9^^172^2262^6
+35 ;;^UTILITY(U,$J,358.3,45282,1,0)
+36 ;;=^358.31IA^4^2
+37 ;;^UTILITY(U,$J,358.3,45282,1,3,0)
+38 ;;=3^DM Type 1 w/o complications
+39 ;;^UTILITY(U,$J,358.3,45282,1,4,0)
+40 ;;=4^E10.9
+41 ;;^UTILITY(U,$J,358.3,45282,2)
+42 ;;=^5002626
+43 ;;^UTILITY(U,$J,358.3,45283,0)
+44 ;;=E11.42^^172^2262^7
+45 ;;^UTILITY(U,$J,358.3,45283,1,0)
+46 ;;=^358.31IA^4^2
+47 ;;^UTILITY(U,$J,358.3,45283,1,3,0)
+48 ;;=3^DM Type 2 w/ diabetic polyneuropathy
+49 ;;^UTILITY(U,$J,358.3,45283,1,4,0)
+50 ;;=4^E11.42
+51 ;;^UTILITY(U,$J,358.3,45283,2)
+52 ;;=^5002646
+53 ;;^UTILITY(U,$J,358.3,45284,0)
+54 ;;=E11.65^^172^2262^8
+55 ;;^UTILITY(U,$J,358.3,45284,1,0)
+56 ;;=^358.31IA^4^2
+57 ;;^UTILITY(U,$J,358.3,45284,1,3,0)
+58 ;;=3^DM Type 2 w/ hyperglycemia
+59 ;;^UTILITY(U,$J,358.3,45284,1,4,0)
+60 ;;=4^E11.65
+61 ;;^UTILITY(U,$J,358.3,45284,2)
+62 ;;=^5002663
+63 ;;^UTILITY(U,$J,358.3,45285,0)
+64 ;;=E11.9^^172^2262^9
+65 ;;^UTILITY(U,$J,358.3,45285,1,0)
+66 ;;=^358.31IA^4^2
+67 ;;^UTILITY(U,$J,358.3,45285,1,3,0)
+68 ;;=3^DM Type 2 w/o complications
+69 ;;^UTILITY(U,$J,358.3,45285,1,4,0)
+70 ;;=4^E11.9
+71 ;;^UTILITY(U,$J,358.3,45285,2)
+72 ;;=^5002666
+73 ;;^UTILITY(U,$J,358.3,45286,0)
+74 ;;=E13.42^^172^2262^12
+75 ;;^UTILITY(U,$J,358.3,45286,1,0)
+76 ;;=^358.31IA^4^2
+77 ;;^UTILITY(U,$J,358.3,45286,1,3,0)
+78 ;;=3^DM oth w/ diabetic polyneuropathy
+79 ;;^UTILITY(U,$J,358.3,45286,1,4,0)
+80 ;;=4^E13.42
+81 ;;^UTILITY(U,$J,358.3,45286,2)
+82 ;;=^5002686
+83 ;;^UTILITY(U,$J,358.3,45287,0)
+84 ;;=E16.2^^172^2262^22
+85 ;;^UTILITY(U,$J,358.3,45287,1,0)
+86 ;;=^358.31IA^4^2
+87 ;;^UTILITY(U,$J,358.3,45287,1,3,0)
+88 ;;=3^Hypoglycemia, unspecified
+89 ;;^UTILITY(U,$J,358.3,45287,1,4,0)
+90 ;;=4^E16.2
+91 ;;^UTILITY(U,$J,358.3,45287,2)
+92 ;;=^5002708
+93 ;;^UTILITY(U,$J,358.3,45288,0)
+94 ;;=E46.^^172^2262^26
+95 ;;^UTILITY(U,$J,358.3,45288,1,0)
+96 ;;=^358.31IA^4^2
+97 ;;^UTILITY(U,$J,358.3,45288,1,3,0)
+98 ;;=3^Malnutrition, protein-calorie, unspec
+99 ;;^UTILITY(U,$J,358.3,45288,1,4,0)
+100 ;;=4^E46.
+101 ;;^UTILITY(U,$J,358.3,45288,2)
+102 ;;=^5002790
+103 ;;^UTILITY(U,$J,358.3,45289,0)
+104 ;;=E53.8^^172^2262^31
+105 ;;^UTILITY(U,$J,358.3,45289,1,0)
+106 ;;=^358.31IA^4^2
+107 ;;^UTILITY(U,$J,358.3,45289,1,3,0)
+108 ;;=3^Vitamin B group deficiency
+109 ;;^UTILITY(U,$J,358.3,45289,1,4,0)
+110 ;;=4^E53.8
+111 ;;^UTILITY(U,$J,358.3,45289,2)
+112 ;;=^5002797
+113 ;;^UTILITY(U,$J,358.3,45290,0)
+114 ;;=E66.01^^172^2262^27
+115 ;;^UTILITY(U,$J,358.3,45290,1,0)
+116 ;;=^358.31IA^4^2
+117 ;;^UTILITY(U,$J,358.3,45290,1,3,0)
+118 ;;=3^Obesity, morbid
+119 ;;^UTILITY(U,$J,358.3,45290,1,4,0)
+120 ;;=4^E66.01
+121 ;;^UTILITY(U,$J,358.3,45290,2)
+122 ;;=^5002826
+123 ;;^UTILITY(U,$J,358.3,45291,0)
+124 ;;=E66.9^^172^2262^28
